002432SZSE

Announcement on the Cancellation of Part of the 2021 Stock Option Incentive Plan

Andon Health Co., Ltd.·

✨ AI Summary

This announcement details the cancellation of 138,750 stock options from the 2021 incentive plan due to employee departures and performance evaluations. The company has completed necessary approvals and procedures for the cancellation and exercise of options. The cancellation is not expected to materially impact the company's financial status or operations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Announcement on the Cancellation of Part of the 2021 Stock Option Incentive Plan

Stock Code: 002432 Stock Abbreviation: KANGHUI MEDICAL Announcement No.: 2026-019

Tianjin KANGHUI MEDICAL ELECTRONICS CO., LTD. Announcement on the Cancellation of Part of the 2021 Stock Option Incentive Plan

The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

Tianjin KANGHUI MEDICAL ELECTRONICS CO., LTD. (hereinafter referred to as the "Company") convened the Fourth Meeting of the Seventh Board of Directors on April 28, 2026, in accordance with the authorization of the Second Extraordinary General Meeting of Shareholders in 2021, and deliberated and approved the "Proposal on Cancelling Part of the Stock Options of the 2021 Stock Option Incentive Plan." The specific situation is as follows:

I. Decision-Making Procedures and Approval Status of the Company's 2021 Stock Option Incentive Plan

  1. On October 28, 2021, the Fifth Board of Directors' Twentieth Meeting and the Fifth Supervisory Board's Seventeenth Meeting deliberated and approved the "Proposal on the 2021 Stock Option Incentive Plan (Draft) and its Summary," the "Proposal on the Management Measures for the Implementation and Assessment of the 2021 Stock Option Incentive Plan," and the "Proposal on Authorizing the Board of Directors to Handle Matters Related to Equity Incentives." The Company's independent directors issued independent opinions on the above proposals, and Beijing Zhong Yin Law Firm issued a corresponding legal opinion. For details, please refer to the announcement on Juchao Information Network (http://www.cninfo.com.cn) dated October 29, 2021.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.